45.47000 EUR
0.59
1.31%
Last update Dec 15, 2:59 PM CET
Market closed
Day range
45.47000
45.47000
Previous close
44.88000
Open
45.47000
Access this stock data via API
Subscribe
Biomarin Pharmaceutical Inc.
45.47
0.59
1.31%

Statistics

Valuation metrics
Market cap
0
Enterprise value
-289.88M
Trailing P/E (ttm)
20.21
Forward P/E
PEG ratio
Price/Sales (ttm)
0
Price/Book (mrq)
Enterprise Value/Revenue
-0.12
Enterprise Value/EBITDA
-0.53
Overview
Shares outstanding
192.10M
Float
Shares short
% Held by insiders
% Held by institutions
Average volume (10 days)
123
Average volume (90 days)
43
Price summary
52-Week low
44.56
52-Week high
68.22
52-Week change
-37.01 -83.1%
Beta
50-Day moving average
46.27
200-Day moving average
50.58
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
79.67%
Operating margin
19.42%
Operational effectiveness
Return on assets
6.11%
Return on equity
7.54%
Income statement
Revenue (ttm)
2.43B
Revenue per share (ttm)
15.02
Quarterly revenue growth (yoy)
-5.97%
Gross profit (ttm)
1.94B
EBITDA
545.89M
Net income to common (ttm)
363.79M
Diluted EPS (ttm)
2.21
Quarterly earnings growth (yoy)
2.60%
Balance sheet
Total cash (mrq)
341.32M
Total cash per share (mrq)
Total debt (mrq)
514.96M
Total Debt/Equity (mrq)
0.10
Current ratio (mrq)
482.76%
Book value per share (mrq)
Cash flow
Cash flow statement
501.17M
Levered free cash flow (LFCF)
1.45B
Access /statistics data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 9 hours 16 minutes

22:43
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).